Human kallikrein 13 involvement in extracellular matrix degradation
- 11 September 2004
- journal article
- research article
- Published by Elsevier
- Vol. 323 (3) , 1084-1090
- https://doi.org/10.1016/j.bbrc.2004.08.206
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Human Kallikrein 13 Protein in Ovarian Cancer Cytosols: A New Favorable Prognostic MarkerJournal of Clinical Oncology, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Plasmin-induced Migration of Endothelial Cells: A POTENTIAL TARGET FOR THE ANTI-ANGIOGENIC ACTION OF ANGIOSTATINPublished by Elsevier ,2002
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and TribulationsScience, 2002
- Activated Matrix Metalloproteinase-2—A Potential Marker of Prognosis for Epithelial Ovarian CancerGynecologic Oncology, 2002
- Taking Cell-Matrix Adhesions to the Third DimensionScience, 2001
- Expression of Latent Matrix Metalloproteinase 9 (MMP-9) Predicts Survival in Advanced Ovarian CancerGynecologic Oncology, 2001
- Cancer treatment with inhibitors of urokinase-type plasminogen activator and plasminExpert Opinion on Investigational Drugs, 2000
- Identification and Characterization of KLK-L4, a New Kallikrein-like Gene That Appears to be Down-regulated in Breast Cancer TissuesJournal of Biological Chemistry, 2000
- Enzymically amplified time-resolved fluorescence immunoassay with terbium chelatesAnalytical Chemistry, 1992